We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.025 | 1.54% | 1.65 | 1.60 | 1.70 | 1.70 | 1.625 | 1.63 | 27,752,936 | 15:13:46 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0095 | -1.74 | 8.96M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/2/2021 23:49 | now appears that BGF now have their shares cleared , | bunz3 | |
08/2/2021 22:44 | There could still be a back test to the pound... buy the dips | losses | |
08/2/2021 21:06 | stumbleupon, in my opinion as some one who here with a longer term view , better if a gradual move up Tomorrow to around £1,50, better to see any sellers cleared at each level. | bunz3 | |
08/2/2021 21:02 | SO MANY LARGE BUYS why they loading up after this rns Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that it has entered into a distribution agreement with Beckman Coulter Life Sciences ("Beckman Coulter") for its Genedrive® 96 SARS-CoV-2 Kit. The agreement enables Beckman Coulter to sell and distribute genedrive's high-throughput COVID-19 PCR Kit in the United States and Europe for use on upper respiratory viral samples. The agreement is the result of the collaboration agreement announced in August 2020, under which the companies worked to develop and validate a fully automated PCR process for Beckman Coulter's Biomek automated workstation in conjunction with its RNAdvance Viral XP extraction kit. The Genedrive® 96 SARS-CoV-2 test is ideally suited for use on the high throughput robotic Biomek i7 instrument. The ready-to-go nature of the test removes many of the fluid dispensing steps required in competitor assays, increasing the overall throughput of the Biomek compared to using a liquid reagent based test formulation. Full automation of the overall PCR workflow can allow laboratories to run large numbers of tests over extended working hours or workstation platforms. Beckman Coulter estimates that this new turnkey solution could process circa 1,000 PCR samples per Biomek workstation installed during a standard 8-hour working day, using just a 0.5 full-time-equivalent in technician time for processing. | bunz3 | |
08/2/2021 21:01 | keep trying to deramp ,if you short you losing a lot of money not interested in 300p , £10 /£12 or higher more of an interest for me seen that reached at ncyt in months after I bought in at £2,20 When I Seen this RNS Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing to come to a distribution with Beckman Coulter is this one of the best Covid tests that available AND Tonights tweet USA Europe | bunz3 | |
08/2/2021 20:50 | I hope so, i would like to see it hit 200p tomorrow rather then end of the week ;0) | stumbleupon | |
08/2/2021 20:48 | But hey i won't really give a toss, i be out and will go short. | oilisgold | |
08/2/2021 20:47 | Bunz, i know for a fact, you be out well before 200p and will be on another share doing the same. | oilisgold | |
08/2/2021 20:11 | not interested in 300p , £10 /£12 or higher more of an interest for me seen that reached at ncyt in months after I bought in at £2,20 When I Seen this RNS Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing to come to a distribution with Beckman Coulter is this one of the best Covid tests that available AND Tonights tweet USA Europe | bunz3 | |
08/2/2021 19:31 | Looking good here. Onwards and upwards. 200p this week imo | seball | |
08/2/2021 19:29 | Probably more | amaretto1 | |
08/2/2021 19:29 | USA market 4 X UK ... alone !!! | amaretto1 | |
08/2/2021 19:24 | SO MANY LARGE BUYS why they loading up after this rns Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that it has entered into a distribution agreement with Beckman Coulter Life Sciences ("Beckman Coulter") for its Genedrive® 96 SARS-CoV-2 Kit. The agreement enables Beckman Coulter to sell and distribute genedrive's high-throughput COVID-19 PCR Kit in the United States and Europe for use on upper respiratory viral samples. The agreement is the result of the collaboration agreement announced in August 2020, under which the companies worked to develop and validate a fully automated PCR process for Beckman Coulter's Biomek automated workstation in conjunction with its RNAdvance Viral XP extraction kit. The Genedrive® 96 SARS-CoV-2 test is ideally suited for use on the high throughput robotic Biomek i7 instrument. The ready-to-go nature of the test removes many of the fluid dispensing steps required in competitor assays, increasing the overall throughput of the Biomek compared to using a liquid reagent based test formulation. Full automation of the overall PCR workflow can allow laboratories to run large numbers of tests over extended working hours or workstation platforms. Beckman Coulter estimates that this new turnkey solution could process circa 1,000 PCR samples per Biomek workstation installed during a standard 8-hour working day, using just a 0.5 full-time-equivalent in technician time for processing. | bunz3 | |
08/2/2021 19:21 | USA and Europe so many wanting shares as Middle of Month draws closer after this rns David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously. "We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products." The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations. | bunz3 | |
08/2/2021 17:21 | This should go 200p in anticipation. | oilisgold | |
08/2/2021 17:20 | Jack , you will get caught pants down and pounded with a lubricant. | oilisgold | |
08/2/2021 17:15 | You wish. 8-) | hazl | |
08/2/2021 17:04 | Tree shake tomorrow ?? | jackdaw4243 | |
08/2/2021 16:54 | He's not interested in researching l, just prefers to post completely made up comments lolDoesn't have a clue but will post in capital letters so you get the message Ha ha ignore him Better to filter the trolls and let them rot | mcrudden |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions